Clinical Genetic Aspects of Autism Spectrum Disorders
AbstractEarly presumptions opined that autism spectrum disorder (ASD) was related to the rearing of these children by emotionally-distant mothers. Advances in the 1960s and 1970s clearly demonstrated the biologic basis of autism with a high heritability. Recent advances have demonstrated that specific etiologic factors in autism spectrum disorders can be identified in 30%–40% of cases. Based on early reports newer, emerging genomic technologies are likely to increase this diagnostic yield to over 50%. To date these investigations have focused on etiologic factors that are largely mono-factorial. The currently undiagnosed causes of ASDs will likely be found to have causes that are more complex. Epigenetic, multiple interacting loci, and four dimensional causes (with timing as a variable) are likely to be associated with the currently unidentifiable cases. Today, the “Why” is more important than ever. Understanding the causes of ASDs help inform families of important issues such as recurrence risk, prognosis, natural history, and predicting associated co-morbid medical conditions. In the current era of emerging efforts in “personalized medicine”, identifying an etiology will be critical in identifying endo-phenotypic groups and individual variations that will allow for tailored treatment for persons with ASD. View Full-Text
Share & Cite This Article
Schaefer, G.B. Clinical Genetic Aspects of Autism Spectrum Disorders. Int. J. Mol. Sci. 2016, 17, 180.
Schaefer GB. Clinical Genetic Aspects of Autism Spectrum Disorders. International Journal of Molecular Sciences. 2016; 17(2):180.Chicago/Turabian Style
Schaefer, G. B. 2016. "Clinical Genetic Aspects of Autism Spectrum Disorders." Int. J. Mol. Sci. 17, no. 2: 180.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.